Hyglos

About:

Hyglos GmbH is a biotech company which develops bacteriophage-derived recombinant proteins for detection and removal of harmful bacteria.

Website: http://www.hyglos.de

Twitter/X: HyglosGmbH

Top Investors: KfW, Encavis, Danisco A/S, BioFund Management

Description:

As an established Biotech company, Hyglos is dedicated to exploit the biochemical principles evolved by bacteriophages for healthcare applications. The abundance of bacteriophages in nature and the unmet precision in occupying and destroying their host bacteria provide an almost unlimited pool for target-specific protein tools.